Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin Treatment

NCT02967237 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: insulin glargine (U300)

Sponsor

Sanofi